Michael John Tomsicek - Nov 9, 2022 Form 3 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Role
Director
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
Stock symbol
ACRV
Transactions as of
Nov 9, 2022
Transactions value $
$0
Form type
3
Date filed
11/9/2022, 07:30 PM
Previous filing
Oct 21, 2022
Next filing
Nov 16, 2022

No securities are beneficially owned.

Remarks:

No securities beneficially owned. Exhibit List - Exhibit 24 - Power of Attorney